Furthermore, activation of pDCs has been shown to induce anti-tumor immunogenic responses and several pDC clinical trials have shown promising clinical benefits in human cancers, suggesting that pDCs could be employed to induce anti-tumor immunity [64,80,81,82,83,84,85,86] (Table 1). Here, PDC is linked to neoplasm.